Skip to content

Medical emergency? What to do

US says two flu drugs unlikely to work

3-RXPublished January 17, 20062 min read

Key points

  • U.S. doctors should stop using two antiviral drugs to treat this season's influenza because the dominant strain has become resistant to the drugs, health officials said on Saturday.
  • Tests of 120 samples of the H3N2 flu strain -- the major one causing flu illness in the United States -- showed it was resistant to amantadine and rimantadine in 91 percent of cases, Centers for Disease Control and Prevention Director Julie Gerberding said.
  • "Physicians should not use amantadine and rimantadine to prevent flu or to treat patients suspected of having influenza because the drugs will not be effective," Gerberding said at a news conference.
  • Amantadine and rimantadine are generic medicines used less often than the newer drugs.

U.S. doctors should stop using two antiviral drugs to treat this season's influenza because the dominant strain has become resistant to the drugs, health officials said on Saturday.

The alert about antiviral pills amantadine and rimantadine applies to the seasonal influenza, not the H5N1 avian flu strain that experts fear could mutate and cause a global pandemic.

Tests of 120 samples of the H3N2 flu strain -- the major one causing flu illness in the United States -- showed it was resistant to amantadine and rimantadine in 91 percent of cases, Centers for Disease Control and Prevention Director Julie Gerberding said.

Only 11 percent of cases were resistant to the two drugs during the last flu season.

"Physicians should not use amantadine and rimantadine to prevent flu or to treat patients suspected of having influenza because the drugs will not be effective," Gerberding said at a news conference.

Doctors instead should prescribe either of two newer medicines, Tamiflu or Relenza, which still fight the strain, she said.

Amantadine and rimantadine are generic medicines used less often than the newer drugs. The older medicines are cheaper and sometimes prescribed to nursing home patients during a flu outbreak to prevent infection.

"We don't think this (new advice) is going to affect a large number of patients because not many patients are typically treated with amantadine and rimantadine," Gerberding said.

Still, officials thought it was important to hold a Saturday news conference to get their advice out quickly, she said.

It was unclear whether the flu virus spontaneously mutated or if something else caused the spike in resistance, Gerberding said. Some experts think over-the-counter sales of the drugs overseas may have increased exposure enough for the virus to adapt and evade the medicines.

Flu cases are now widespread in seven U.S. states, mostly in the South and Southwest regions, Gerberding said, adding it was too early to say if this year's outbreak had peaked.

Tamiflu and Relenza are in demand globally as countries rush to stockpile them in case the avian flu virus mutates to a form that is highly lethal and easy to transmit among people.

Gerberding said there was enough supply of both to meet the needs for the regular flu this season.

Roche AG sells Tamiflu, and developer Gilead Sciences Inc. receive royalties on the drug's sales. Relenza, which must be inhaled, is sold by GlaxoSmithKline Plc. It was developed by Biota Holdings Ltd.

Tamiflu is known generically as oseltamivir and Relenza as zanamivir.

Several generic makers sell amantadine and rimantadine.

Vaccines to prevent flu infection still are available, officials said.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underDrug Abuse
Cancer

EU to take another look at GSK breast cancer drug

Europe's drugs regulators will take another look at GlaxoSmithKline Plc's new breast cancer pill Tyverb after new data showed a small risk of higher liver enzymes during treatment with the drug. GSK, Europe's biggest…

2 min read

Drug Abuse

Study raises caution on new painkillers

A new class of painkillers that block a receptor called TRPV1 may interfere with brain functions such as learning and memory, a new study suggests. The experiments with rat brain found that the TRPV1 receptor…

4 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.